Information  X 
Enter a valid email address

CRH PLC (CRH)

  Print      Mail a friend       Annual reports

Friday 28 February, 2020

CRH PLC

Board Changes

RNS Number : 5102E
CRH PLC
28 February 2020
 

Press Release

Board Changes

 

CRH plc, the leading building materials business in the world, announces that, as part of the Board's renewal process, Patrick Kennedy and Henk Rottinghuis are not seeking re-election at the Annual General Meeting to be held on 23 April 2020 and will, therefore, step down from the Board at the conclusion of that meeting.

 

Commenting on the retirements, Mr. Richie Boucher, Chairman of CRH, said: "On behalf of the Board I would like to thank Pat and Henk for their commitment and great service to CRH over many years and wish them both every success in the future."

 

****

Contact CRH at Dublin 404 1000 (+353 1 404 1000)

 

Tom Holmes

Head of Investor Relations

 

 

About CRH

CRH (LSE: CRH, ISE: CRG, NYSE: CRH) is the leading building materials business in the world, employing c.80,000 people at c.3,100 operating locations in 30 countries. It is the largest building materials business in North America, a leading heavyside materials business in Europe and has positions in Asia and South America. CRH manufactures and supplies a range of integrated building materials, products and innovative solutions which can be found throughout the built environment, from major public infrastructure projects to commercial buildings and residential structures. A Fortune 500 company, CRH is a constituent member of the FTSE 100 Index, the EURO STOXX 50 Index, the ISEQ 20 and the Dow Jones Sustainability Index (DJSI) Europe. CRH's American Depositary Shares are listed on the NYSE.

 

For more information visit www.crh.com .

 

Registered Office: No 12965. Registered Office: 42 Fitzwilliam Square, Dublin 2, R02 R279, Ireland

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOATPMBTMTMTBTM

a d v e r t i s e m e n t